Ισραήλ - Εβραϊκά - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 5 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Ισραήλ - Εβραϊκά - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 10 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Ισραήλ - Εβραϊκά - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 20 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Ισραήλ - Εβραϊκά - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 40 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Ισραήλ - Εβραϊκά - Ministry of Health

padagis israel pharmaceuticals ltd, israel - glipizide - טבליה - glipizide 5 mg - glipizide - glipizide - is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with diabetes mellitus type ii

Ισραήλ - Εβραϊκά - Ministry of Health

padagis israel pharmaceuticals ltd, israel - bifonazole - ג'ל - bifonazole 1 %w/w - bifonazole - bifonazole - broad spectrum antimycotic agent.

Ισραήλ - Εβραϊκά - Ministry of Health

padagis israel pharmaceuticals ltd, israel - bifonazole - תמיסה - bifonazole 1 %w/v / 100 ml - bifonazole - bifonazole - broad spectrum antimycotic agent.

Ισραήλ - Εβραϊκά - Ministry of Health

padagis israel pharmaceuticals ltd, israel - butenafine hydrochloride - קרם - butenafine hydrochloride 1 % - butenafine - butenafine - interdigital tinea pedis, tinea coporis, tinea cruris . (treatment in tinea coporis and tinea cruris is limited to up to 4 weeks).

Ισραήλ - Εβραϊκά - Ministry of Health

perrigo israel pharmaceuticals ltd - crotamiton; sulphur precipitated - קרם - crotamiton 10 %; sulphur precipitated 8 % - combinations of corticosteroids - combinations of corticosteroids - anti scabies treatment, symptomatic treatment of skin irritation.

Ισραήλ - Εβραϊκά - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - קרם וגינלי - clotrimazole 2 % - clotrimazole - clotrimazole - broad spectrum antimycotic with fungicidal action